Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-652 in Diabetic Neuropathic Pain
NCT01579279Phase 2Terminated
- Sponsor
- AbbVie Inc.
- Start
- Apr 2012
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABT-652 in diabetic neuropathy, sponsored by AbbVie Inc.. Started Apr 2012; status: terminated.
02
Drugs
ABT-652
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01579279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579279.